基本信息
浏览量:332
职业迁徙
个人简介
Has a track record of designing and conducting clinical trials of novel therapies and modalities. Has obtained funding through the Dept of Defense, Prostate cancer Foundation and National Cancer Institute with a goal towards developing precision medicine/individualized therapy for each patient with cancer. Currently working on discovery of a novel cancer screening and/or early detection techniques. Dr Vaishampayan has helped develop and bring to FDA approval a number of therapies in cancer. She is a proponent of the 3 Rs in oncology; Rapidly obtaining the right drug to the right patient.
研究兴趣
论文共 634 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Journal of Clinical Oncologyno. 4_suppl (2024): 467-467
CANCER MEDICINEno. 5 (2024)
U.N. Vaishampayan,D. Kilari,T.B. Dorff, J. Taylor, J.T. Brown, A.O. Sokolova,Z. Reichert,P. Palmbos, I. Tsung, M. Caram, S. Yentz,J. Alumkal,
Annals of Oncology (2024)
EUROPEAN UROLOGYno. 3 (2024): 258-264
PROSTATE CANCER AND PROSTATIC DISEASES (2024)
Journal of Clinical Oncologyno. 16_suppl (2024): 2507-2507
crossref(2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn